S2-E25.2 (CORRECTED) - Prevalence of NAFLD and NASH 2021 -- Deeper Dive

Send us a text

(This episode has been reposted to include the complete conversation content.)

Louise Campbell and Roger Green join co-authors Stephen Harrison, Naim Alkhouri and first-time guest Prof. Samer Gowrieh to dive deeper into key findings from the 2021 Journal of Hepatology paper titled "Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort."

A deeper dive into the data coming from the 2021 Journal of Hepatology paper "Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort" reveals several troubling trends, including percentages of patients with F2/F3 NASH increasing far faster than the overall NAFLD growth rate and population subgroups in which a majority of the study patients exhibited NAFLD and over one in three exhibited NASH. Whether you are familiar with the paper or not, you will want to listen to this conversation to hear points you might have missed.